`
`Before the Patent Trial and Appeal Board
`
`FLATWING PHARMACEUTICALS, LLC,
`Petitioner,
`
`v.
`
`ANACOR PHARMACEUTICALS, INC.,
`Patent Owner
`
`U.S. Patent No. 9,549,938 to Baker et al.
`Ser. No. 15/068,352, filed March 11, 2016
`Issue Date: January 24, 2017
`
`Title: BORON-CONTAINING SMALL MOLECULES
`______________________
`
`Inter Partes Review No. IPR2018-00168
`______________________
`
`PETITIONER FLATWING PHARMACEUTICALS, LLC’S POWER OF
`ATTORNEY (INTER PARTES REVIEW OF U.S. PATENT NO. 9,549,938)
`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), FlatWing Pharmaceuticals, LLC
`
`(“Petitioner”) hereby appoints Philip D. Segrest, Jr., Reg. No. 39,021 and Eric J.
`
`Rakestraw, Reg. No. 68,740 as attorneys to represent the undersigned before the
`
`United States Patent and Trademark Office (USPTO) in connection with all
`
`transactions associated with this petition for inter partes review.
`
`Lead Counsel
`Philip D. Segrest, Jr.
`Reg. No. 39,021
`Husch Blackwell LLP
`120 South Riverside Plaza, Suite 2200
`Chicago, Illinois 60606
`(312) 655-1500 Tel
`(312) 655-1501 Fax
`Philip.Segrest@huschblackwell.com
`
`Backup Counsel
`Eric J. Rakestraw
`Reg. No. 68,740
`Husch Blackwell LLP
`190 Carondelet Plaza, Suite 600
`St. Louis, MO 63105
`(314) 480-1500 Tel
`(314) 480-1505 Fax
`Eric.Rakestraw@huschblackwell.com
`
`FOR: FlatWing Pharmaceuticals, LLC
`
`SIGNATURE: ________________________________
`
`PRINTED NAME: ________________________________
`
`TITLE: ________________________________
`
`DATE: ________________________________
`
`R. K. Ahuja
`
`Member
`
`11/7/2017
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.105, Petitioner certifies that this Power of
`
`Attorney was served by Federal Express, on November 21, 2017, to the
`
`Patent Owner owner of U.S. Patent No. 9,549,938, Anacor Pharmaceuticals, Inc.,
`
`at their correspondence address of record according to USPTO PAIR:
`
`MORGAN, LEWIS & BOCKIUS LLP (SF)
`Attn: Todd Esker
`One Market, Spear Street Tower, Suite 2800
`San Francisco CA 94105
`
`and that additional copies have been delivered to the address of the patent owner
`
`according to the assignments of record at the USPTO at:
`
`ANACOR PHARMACEUTICALS, INC.
`Attn: Ryan Walsh, Vice-President & Chief IP counsel
`1020 East Meadow Circle
`Palo Alto, CA 94303
`
`and to additional counsel at the following addresses:
`
`COVINGTON & BURLINGTON LLP
`Attn: Andrea Reister, Enrique Longton, and George F. Pappas
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`
`On this the 21st day of November 2017.
`
` Respectfully submitted,
`/Philip D. Segrest, Jr./
`Philip D. Segrest Jr. (Reg. No. 39,021)
`philip.segrest@huschblackwell.com
`Lead Counsel for Petitioner
`Eric J. Rakestraw (Reg. No. 68,740)
`Eric.Rakestraw@HuschBlackwell.com
`
`
`
`Backup Counsel for Petitioner
`HUSCH BLACKWELL LLP
`120 South Riverside Plaza, Suite 2200
`Chicago, IL 60606
`Tel. 312-655-1500
`Fax. 312-644-1501
`
`